InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.07
(
0.90%
)
US TECH 100
19,476.00
(
1.10%
)
Dow Jones
42,352.75
(
0.81%
)
Brent Oil
77.97
(
0.00%
)
Bitcoin
62,696.21
(
1.00%
)
Post# of 253281
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120535
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 17488

Thursday, 10/27/2005 11:26:49 AM

Thursday, October 27, 2005 11:26:49 AM

Post# of 253281
Erbitux 3Q05 factoids

17% of sales were in combination with both Avastin and chemo;
68% of sales were in combination with chemo (but not Avastin);
15% of sales were in monotherapy.

79% of sales were in colorectal cancer (the rest in H&N, pancreatic, and lung).

Penetration in colorectal cancer:
1st-line: 4%; 2nd-line: 14%; 3rd-line 30%.

Source: IMCL CC

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up